COMMUNIQUÉS West-GlobeNewswire

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
21/04/2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a [...]
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
21/04/2025
Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapies NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN [...]
BioCryst to Report First Quarter 2025 Financial Results on May 5
21/04/2025
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025 [...]
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
21/04/2025
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to [...]
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
21/04/2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director [...]
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
21/04/2025
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to [...]
Apellis Announces Craig Wheeler to Join the Board of Directors
21/04/2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the [...]
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
21/04/2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
21/04/2025
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its [...]
Alumis and ACELYRIN Announce Amended Merger Agreement
21/04/2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company [...]
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
21/04/2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it [...]
Alumis and ACELYRIN Announce Amended Merger Agreement
21/04/2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company [...]
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
21/04/2025
Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% [...]
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
21/04/2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve [...]
Boston Hemp Launches New Line of Premium THCa Concentrates
20/04/2025
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in compliant hemp-derived cannabis, today announced the launch of its new line of premium THCa concentrates , now available to consumers [...]
PhenQ Reviews - Best OTC Ozempic Alternative for Natural Weight Loss
20/04/2025
Albany, New York, April 20, 2025 (GLOBE NEWSWIRE) -- The Rise of Weight Management Challenges in the Modern World Across the globe, millions of people are grappling with weight loss more than ever, often feeling [...]
Bioma Review 2025: Weight Loss Probiotic or Just Another Scam? - Ingredients & Side Effects Revealed !! By Bioma
20/04/2025
Birštonas Lithuania, April 20, 2025 (GLOBE NEWSWIRE) -- Are you looking for a reliable solution to improve your gut health and overall well-being? Bioma Probiotic could be the answer you've been searching for. This [...]
GenF20 Plus Under Review: Why Choose GenF20 Plus Over The Other Popular HGH Releaser Supplement?
20/04/2025
GenF20 Plus® is an all-natural supplement that is clinically-proven to reverse the signs of aging by boosting your Human Growth Hormone (HGH) levels. Limassol, Cyprus, April 20, 2025 (GLOBE NEWSWIRE) -- GenF20 Plus is [...]
Riyadh Ignites Global Healthcare Innovation at MESH Core 2025
20/04/2025
Mass General Brigham and Saudi healthcare leaders collaborate to redefine the future of healthcare through AI, gene therapy, and venture-backed innovation RIYADH, Saudi Arabia, April 20, 2025 (GLOBE NEWSWIRE) -- MESH [...]

Pages